InterCure (INCR) Financial Statements & Analysis

InterCure Income Statement Analysis

Values in millions ILS

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

InterCure Ltd. income statement - Annual data in millions ILS
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Mar 2023	Dec 2022	Mar 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Revenue & Gross Profit
Revenue	270.20	238.85	355.55	388.68	388.68	219.68	219.68	65.04	8.93	0.00	0.00
Cost of Revenue	237.02	208.61	246.95	233.60	216.67	128.55	128.55	34.65	7.45	0.00	0.00
Gross Profit	33.18	30.23	105.10	155.08	155.08	91.13	91.13	33.59	1.48	0.00	0.00
Operating Expenses
Research & Development	0.39	0.41	0.39	0.63	0.63	1.24	1.24	1.58	1.71	0.00	0.00
Selling, General & Administrative	80.41	84.63	95.88	97.32	92.62	53.46	53.46	17.03	81.96	9.81	1.12
Operating Expenses	26.45	97.44	150.43	95.24	134.44	62.95	58.11	34.79	4.89	9.81	1.12
Operating Income	6.73	-67.21	-41.57	50.63	50.63	28.19	33.02	-1.21	-3.42	-10.62	-3.98
Other Income/Expense
Interest Income	1.56	2.70	5.88	0.84	8.17	0.13	0.13	0.62	0.14	0.00	0.00
Interest Expense	19.66	22.79	-24.22	14.96	-14.69	5.05	5.05	-0.26	1.97	1.03	0.64
Other Income/Expense	-50.84	-20.12	-19.72	-6.79	-6.79	-9.45	-9.38	-0.26	-3.15	-2.18	-1.28
Income
Income Before Tax	-44.10	-87.32	-61.29	43.84	43.84	18.74	18.73	-38.31	-6.57	-12.80	-5.26
Income Tax Expense	-7.32	-14.53	2.25	0.09	0.09	11.44	11.44	-2.27	-0.67	0.00	0.66
Net Income	-35.71	-67.80	-61.96	44.82	44.82	4.69	4.69	-37.23	-5.89	-12.80	-5.26
Net Income - Continuous Operations	-35.71	-67.80	-63.53	44.82	43.75	4.69	7.29	-37.23	-5.89	-12.80	-5.26
Net Income - Discontinued Operations	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-7.29	-51.31	13.27	70.23	51.93	31.17	31.17	-35.15	-3.77	-10.12	-1.15
EBIT	-67.24	-87.89	0.11	-	40.23	-	23.78	-38.40	-	-	-
Depreciation & Amortization	17.15	15.37	8.18	11.70	11.70	7.39	2.93	3.25	0.83	0.01	0.00
Earnings Per Share
Basic EPS	-3.00	-7.00	-7.00	5.00	5.00	1.00	-	-1.00	-1.00	-3.00	-2.00
Diluted EPS	-3.00	-7.00	-1.00	5.00	1.00	1.00	-	-1.00	-1.00	-3.00	-2.00
Basic Shares Outstanding	11.36	9.11	9.11	9.07	9.07	7.70	38.49	25.40	4.66	4.12	3.36
Diluted Shares Outstanding	11.36	9.11	9.11	9.07	9.07	8.17	46.92	25.40	4.66	4.12	3.42

Source: Company financial statements from annual and quarterly filings. Data as of Dec 31, 2025. Data sources and methodology

Frequently Asked Questions About InterCure Financial Statements

What was InterCure's revenue in fiscal 2025?

InterCure reported revenue of ILS 270.20M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 13.1% from ILS 238.84M a year earlier.

Is InterCure profitable?

No. InterCure reported a net loss of ILS 35.71M in fiscal 2025. In fiscal 2024 it lost ILS 67.80M.

What is InterCure's operating margin?

InterCure's operating income was ILS 6.73M on revenue of ILS 270.20M in fiscal 2025, an operating margin of 2.5%, compared with -28.1% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition